Loading stock data…
TKNO
$3.40-0.15 (-4.23%)
Market ClosedLast close May 1
Alpha Teknova, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Alpha Teknova, Inc. in the Healthcare sector is trading at $3.40. The stock is currently 55% below its 52-week high of $7.48, remaining 14.8% below its 200-day moving average. Technical signals show neutral RSI of 60 and bullish MACD crossover, explaining why TKNO maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 60) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$3.40
Potential Upside
5%
Whystock Fair Value$3.57
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Buy
Mean target$9.00+164.7%
Range$7.00 – $12.00
Fundamentals
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured me...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$172.36M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.33
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-25.09%
Volume
Today's trading volume
90,150
Recent News
Top Penny Stocks To Watch In April 2026
Over the last 7 days, the U.S. market has risen by 1.7%, and in the past year, it has climbed 34%, with earnings forecast to grow by 16% annually. Penny stocks might seem like a relic of past market eras, but they still hold potential when backed by strong financials, offering affordability and growth opportunities that larger firms may overlook. In this article, we'll explore three penny stocks that stand out for their financial strength and potential to offer compelling opportunities for...
Favourable Signals For Alpha Teknova: Numerous Insiders Acquired Stock
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
Alpha Teknova Conference: TKNO Targets EBITDA Profit by 2027 as Clinical Solutions Gains Traction
Alpha Teknova (NASDAQ:TKNO) outlined its growth strategy and path toward profitability during a company presentation, emphasizing a steady “Lab Essentials” foundation and a higher-growth “Clinical Solutions” segment tied to therapies and diagnostics moving through clinical development. 2025 results
Alpha Teknova Q4 Earnings Call Highlights
Alpha Teknova (NASDAQ:TKNO) executives told investors the company delivered faster growth and improved profitability metrics in 2025, and said they believe the business is approaching an “inflection point” as it scales its mix of research-grade and GMP-grade reagents. On the company’s fourth-quarter
Alpha Teknova, Inc. Q4 2025 Earnings Call Summary
Moby summary of Alpha Teknova, Inc.'s Q4 2025 earnings call